Two companies in BICO’s Biosciences business area have taken home Red Dot accolades for their groundbreaking product design.
Today, Discover Echo and CYTENA BPS, two companies’ part of the BICO Bioscience business areas were recipients of the illustrious Red Dot Design awards. CYTENA BPS’ S.NEST™ was further recognized as part of the “Best of the Best”, the highest accolade available.
“This marks BICO’s third year in a row being recognized by the Red Dot committee, a wonderful testament to the passion and persistence shown across the organization to develop user centric designed products that truly disrupt workflows in the life sciences industry. This recognition inspires us to continue to focus on design across the group” says Markus Grip, Head of Brand & Design at BICO.
The Red Dot Award is an international competition with a focus on recognizing leading product design across a variety of disciplines. Typically, the organization receives thousands of entrants from a range of organizations. Applications are reviewed by an international jury, comprised of experienced experts from different disciplines and has been convening for over 60 years. The jurors test all the entries to assess not just the aesthetic but also the materials selected, the level of craftsmanship, the surface structure, ergonomics, and functionality.
About CYTENA’s product S.NEST™:
The S.NEST, a high-throughput microbioreactor with CO2 incubator functions, shortens the process time for cell upscaling, provides a better microscale environment for cell growth, and brings more efficiency to cell line selection. More information about the product: https://www.cytena.com/s-nest-the-next-generationmicrobioreactor-for-cell-line-development/
About Discover Echo’s product Revolution:
Revolution reinvents automated microscopy by offering the ability to image with Transmitted Light, Phase contrast, and Fluorescence and can convert between both Upright and Inverted configurations. Revolution is driven by Discover Echo’s ’software module Surface Studio bringing a more collaborative and intuitive experience to the user by eliminating the need for eyepieces. More information about the product:
For further information, please contact:
Avijit Minocha, Head of Marketing, BICO
Phone (US): +1 (617) 637 5372
Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people’s health and lives for the better.
The company has a focus on developing technologies that will advance Health 4.0 Next Generation Core Industry Ecosystems that enable tissue engineering, diagnostics, multiomics, and cell line development. BICO’s technologies enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health.
The Group’s instruments in the field amounts to 25,000, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 9,500 publications. BICO is listed on Nasdaq Stockholm under BICO. www.bico.com